Pasithea Therapeutics Statistics Share Statistics Pasithea Therapeutics has 7.44M
shares outstanding. The number of shares has increased by 612.93%
in one year.
Shares Outstanding 7.44M Shares Change (YoY) 612.93% Shares Change (QoQ) 175.15% Owned by Institutions (%) 0.99% Shares Floating 6.84M Failed to Deliver (FTD) Shares 30,779 FTD / Avg. Volume 20.58%
Short Selling Information The latest short interest is 32.57K, so 0.44% of the outstanding
shares have been sold short.
Short Interest 32.57K Short % of Shares Out 0.44% Short % of Float 0.44% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.25 and the forward
PE ratio is null.
Pasithea Therapeutics's PEG ratio is
-0.79.
PE Ratio -0.25 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.23 P/FCF Ratio 0 PEG Ratio -0.79
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pasithea Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.58,
with a Debt / Equity ratio of 0.
Current Ratio 6.58 Quick Ratio 6.58 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.48M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -81.88% in the
last 52 weeks. The beta is 0.28, so Pasithea Therapeutics's
price volatility has been higher than the market average.
Beta 0.28 52-Week Price Change -81.88% 50-Day Moving Average 0.73 200-Day Moving Average 1.48 Relative Strength Index (RSI) 51.65 Average Volume (20 Days) 149,574
Income Statement
Revenue n/a Gross Profit -649.03K Operating Income -14.25M Net Income -13.9M EBITDA -13.26M EBIT -13.9M Earnings Per Share (EPS) -12.69
Full Income Statement Balance Sheet The company has 6.92M in cash and 0 in
debt, giving a net cash position of 6.92M.
Cash & Cash Equivalents 6.92M Total Debt n/a Net Cash n/a Retained Earnings -49.58B Total Assets 17.01M Working Capital 6.9M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -13.92B
and capital expenditures 0, giving a free cash flow of -13.92B.
Operating Cash Flow -13.92B Capital Expenditures n/a Free Cash Flow -13.92B FCF Per Share -12702.92
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields KTTA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for KTTA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 2, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Jan 2, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -4.83 Piotroski F-Score 1
